A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Continuing Medical Education

Continuing Medical Education
City of Hope has a long-standing commitment to continuing medical education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.

CME events are vital for physicians seeking board certification and for maintenance of certification, or MOC, ensuring that they are kept up to date on the latest treatment modalities and delivering the highest standard of patient care.
One of the Top ACCME-accredited CME Program Providers

City of Hope’s CME program has been fully accredited since 1999 through the Accreditation Council for Continuing Medical Education (ACCME) to provide AMA PRA Category 1 CreditTM. In 2005, our CME Program received its first Accreditation with Commendation. This designation placed our CME Program in the top 1 to 2 percent of CME program providers in the nation. In 2011, the ACCME awarded our CME Program its second consecutive Accreditation with Commendation designation citing compliance in all 22 Criteria and Accreditation Policies and characterizing our CME Program as having "...demonstrated an engagement with your environment in support of physician learning and change that is part of a system of quality improvement."
A Founding Member of NCCN

City of Hope is a founding member of the NCCN (National Comprehensive Cancer Network), a not-for-profit alliance of 21 of the nation’s leading cancer centers. The NCCN develops clinical practice guidelines for use by patients, physicians and other health care decision-makers. The NCCN Drugs and Biologics Compendium is a regularly-updated, comprehensive set of guidelines which recommends the most appropriate diagnostic tests, therapy and follow-up for cancer patients based on clinical evidence as well as the consensus of leading academic cancer centers.

City of Hope’s expert doctors contribute to the NCCN Compendium on an ongoing basis, and CME courses offered by City of Hope are consistently informed by NCCN guidelines.

CME e-Learning

City of Hope's Department of Continuing Medical Education offers accredited e-Learning courses/programs in addition to conferences and symposiums.

Immunization Initiative

City of Hope has undertaken an Immunization Initiative to help both healthcare providers and patients more aware of the need to be current with immunizations. Many adults assume that immunizations they received as children will protect them for a lifetime. While this is true for some vaccinations, oncologists, primary care physicians, and others who manage patients with cancer need to be aware that some adults have never received certain childhood immunizations and that newer vaccines may not have been available to them as children. Furthermore, immunity conferred by some vaccines fades over time, an effect that may be exacerbated in patients with cancer or who might be otherwise immunocompromised.
Questions regarding this project or to learn how to get involved please contact the Continuing Medical Education Department at 626-256-4673 ext 65622 or email us at cme@coh.org.
The education and information provided has been developed in collaboration between City of Hope and The France Foundation and sponsored by an educational research grant by Pfizer.


Support Materials

VTE Prophylaxis

Patients with cancer, particularly those undergoing active treatment, frequently experience thromboembolic events. Despite the availability of many guidelines for VTE prophylaxis data demonstrate that there is a discordance between guidelines and practice. In point of fact, VTE is a leading cause of morbidity in patients with cancer.
To support our staff in the furtherance of excellent treatment provided by City of Hope, the Department of Continuing Medical Education will release an accredited series of educational interventions the focus of which will be the prevention and decrease of Venous Thromboembolic Events.
This series has been made possible by support from the Unihealth Foundation.
On the Go
Hear what experts have to say about Venous Thromboembolic Events. The following can be completed in 20 minutes or less.

More Time

Receive Credit
To receive AMA PRA Category 1 Credit(s)tm you must:
  1. Register for each individual program
  2. View course materials
  3. Pass each post test with 70% or better
  4. Complete the activity evaluation
If you have any questions regarding credits, please contact the Department of Continuing Medical Education at : 626-256-4673 ext 65622 or cme@coh.org.

Clinical Updates

City of Hope Continuing Medical Education Department is committed to providing you with the information and resources to facilitate improvement in practice performance patient outcomes.

Please review the the links below:

Contact the Continuing Medical Education Department if you have questions regarding this or any of the information provided at cme@coh.org or 626-256-4673 ext 65622.

Grand Rounds

The Grand Rounds program offered at City of Hope is available to physicians and hospitals in the surrounding areas. Members of the medical staff at City of Hope are available to speak to medical groups, hospital medical staffs and community hospital health-care professionals on a variety of topics related to cancer and other life-threatening diseases. Our speakers can provide expert presentations in various settings, including hospital grand rounds, luncheon and dinner lectures, and CME conferences and symposia. New speakers and topics are added regularly, and we can create custom presentations to meet the specific needs of your organization.
Anatomic Pathology
Central Nervous System
Brain Tumors, Benign
Brain Tumors, Malignant
Brain Tumors, Metastatic
CNS Lymphoma
Pituitary Tumors
Spinal Tumors

Clinical Cancer Genetics
Genetic Counseling
Clinical Molecular Diagnostics
Advances in Testing
Familial Cancer Testing
Hereditary Colon Cancer
Li-Fraumeni Syndrome (the largest clinical experience to date)
Marfan Syndrome
X-link Mental Retardation (a panel of eight genes may detect the underlying mechanism in about 20 percent of families)
Islet Cell Transplantation
Gastrointestinal Cancers
Anal Cancer
Bile Duct Cancer
Colon Cancer
Esophageal Cancer
Gallbladder Cancer
Gastric Cancer
Gastrointestinal Carcinoid Tumors
Liver Cancer
Pancreatic Cancer
Rectal Cancer
Small Intestine Cancer

Genitourinary Cancers
Bladder Cancer
Kidney Cancer
Prostate Cancer
Testicular Cancer
Head and Neck Cancers
Laryngeal Cancer
Oral Cancer

Hematologic Malignancies
Aplastic Anemia
Hematopoietic Stem Cell Transplantation
Leukemia, Acute Lymphoblastic
Leukemia, Acute Myeloid
Leukemia, Acute Promyelocytic
Leukemia, Chronic Lymphocytic
Leukemia, Chronic Myelogenous
Lymphoma, Primary CNS
Lymphoma, Hodgkin’s
Lymphoma, Non-Hodgkin’s
Multiple Myeloma
Myelodysplastic Syndromes
Plasma Cell Neoplasms

Infectious Diseases
Worldwide Swine Flu (AH1N1) Outbreak - CME Module
Musculoskeletal Cancers
Bone and Soft Tissue
Sarcomas and Other Soft Tissue Cancers
Myasthenia Gravis
Robotic Thymectomy
Pain Management and Palliative Care
Pediatric Cancers
Bone and Soft Tissue Cancer
Childhood Brain Tumor
Leukemia, Childhood Acute Lymphoblastic
Leukemia, Childhood Acute Myeloid
Liver Cancer, Childhood
Lymphoma, Childhood Hodgkin’s Disease
Lymphoma, Childhood Non-Hodgkin’s
Skin Cancer

Thoracic Cancers
Lung Cancer, Non-small Cell
Lung Cancer, Small Cell
Mediastinal Tumors

Thyroid Cancer

Women’s Cancers
Breast Cancer
Cervical Cancer
Endometrial/Uterine Cancer
Ovarian Epithelial Cancer
Ovarian Germ Cell Tumor
In addition to those shown here, speakers on a variety of other topics are available. Please contact us for more information.



Accreditation History

We at the City of Hope have had an active Continuing Medical Education program since the 1950's when the school of Postgraduate Medicine first sponsored extramural conferences. Our first accreditation occurred under the aegis of the California Medical Association in 1978. We continued this statewide accreditation until our expanding national course offerings and reputation evolved into an application for national accreditation in 1997. In July 1999, a two-year provisional accreditation status was awarded through ACCME (Accreditation Council for Continuing Medical Education).

In February 2005, our CME Program underwent the ACCME’s rigorous quadrennial reaccreditation review and survey. We were advised by ACCME on July 15, 2005 that we had been Reaccredited with Commendation with Exemplary Compliance demonstrated in six Essential Elements. This designation placed our CME Program in the top one to two percent of CME program providers in the nation. We were also listed as a “best practices” resource on the ACCME website under their Exemplary Compliance List.

On February 24, 2011, our City of Hope CME Program once again underwent ACCME re-accreditation review. On July 22, 2011, the ACCME apprised us of their decision to award our program its second consecutive Accreditation with Commendation citing compliance in all 22 Criteria and Accreditation Policies and characterizing our CME Program as having "...demonstrated an engagement with your environment in support of physician learning and change that is part of a system of quality improvement."



CME Calendar

City of Hope's CME calendar is easy to navigate - just move your cursor over or click a date or event description. You can also add events to your personal calendar, e-mail event information to yourself or others, set up e-mail and cell phone text message reminders on events and other event actions. Additionally, you can subscribe to the CME calendar in different ways including Weekly e-mails, RSS and Atom Feeds.

CME Dinners and Conferences

Regional continuing medical education (CME) events welcome physicians from the surrounding areas for focused sessions on current oncology topics.
Click on topics below to REGISTER NOW!
The Cosmopolitan Hotel in Las Vegas
3708 Las Vegas Blvd South, Las Vegas 89109
November 6-9, 2014
Dinner Meeting Series
Brookside Golf Course: 1133 Rosemont Ave, Pasadena CA 91103
June 25, 2014; Registration: 5:30pm
Athenaeum @ Cal Tech: 511 South Hill Ave, Pasadena CA 91106
July 23, 2014; Registration : 5:30pm
City of Hope Visitor's Center: 1500 E. Duarte Rd, Duarte CA 91010
August 7, 2014; Registration : 5:30pm
City of Hope Visitor's Center: 1500 E. Duarte Rd, Duarte CA 91010
September 4, 2014; Registration : 5:30pm
Brookside Golf Course: 1133 Rosemont Ave, Pasadena CA 91103
September 24, 2014; Registration : 5:30pm
City of Hope Visitor's Center: 1500 E. Duarte Rd, Duarte CA 91010
October 2, 2014; Registration : 5:30pm
City of Hope Visitor's Center: 1500 E. Duarte Rd, Duarte CA 91010
November 13, 2014; Registration : 5:30 pm
City of Hope Visitor's Center: 1500 E. Duarte Rd, Duarte CA 91010
December 4, 2014; Registration : 5:30pm
Brookside Golf Course: 1133 Rosemont Ave, Pasadena CA 91103
December 10, 2014; Registration : 5:30pm
Brookside Golf Course: 1133 Rosemont Ave, Pasadena CA 91103
March 25, 2015; Registration : 5:30pm
Brookside Golf Course: 1133 Rosemont Ave, Pasadena CA 91103
June 24, 2015 ; Registration : 5:30 pm
You also have the opportunity of adding events from the CME Calendar directly to your personal calendar as well as send reminders to yourself. (See Event Actions below calendar.)
Conference Contact
For additional information, please contact course registrar at 626-256-HOPE (4673), Ext. 65622


National and Regional Events and Conferences
City of Hope's Department of Continuing Medical Education now offers accredited e-Learning courses/programs in addition to conferences and symposiums.
For the 11th year, U.S.News & World Report has named City of Hope one of the top cancer hospitals in the country.
Research Videos

Learn more about
City of Hope's institutional distinctions, breakthrough innovations and collaborations.
  • Eleven years ago, lymphoma patient Christine Pechera began the long road toward a cancer-free life. She had been diagnosed with non-Hodgkin lymphoma and told by doctors elsewhere that her lifespan likely would be measured in months, not years. Refusing to give up, she came to City of Hope for a second opinion. ...
  • Brain surgery is not for the faint of heart. It takes courage, as well as curiosity and compassion. The truly great surgeons also have a desire to find new, and better ways, of healing the brain. Enter Behnam Badie, M.D., chief of neurosurgery at City of Hope. Now a pioneer in brain tumor treatment, Badie enter...
  • Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia, or AML. AML arises when abnormal white blood cells grow out of control, amassing in the bone marrow and interfering with normal blood cell developme...
  • Six, to date; more soon. Outpatient bone marrow transplants, that is. Finding new ways to deliver quality care with the greatest benefit is a priority for a patient-centered institution like City of Hope. For example, not every bone marrow transplant patient needs to check into the hospital for treatment. In fa...
  • The best measure of success in the fight against cancer is in lives saved and families intact, in extra days made special simply because they exist. Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, understands what precedes that special awareness. When cancer strikes, one minute a person ma...
  • In cancer, expertise matters. So do survival rates, patient safety, patient services and many other factors. City of Hope understands this, as does U.S.News & World Report. The magazine’s 2014-2015 list of best hospitals for cancer once again includes City of Hope, ranking the institution 12 out of 900 elig...
  • At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer. ...
  • The well-known drug tamoxifen might not always be the best choice for premenopausal women who have undergone treatment for breast cancer and face a heightened risk of recurrence. A new study suggests that the aromatase inhibitor exemestane, or Aromasin, works slightly better than tamoxifen in preventing cancer ...
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. The cancer grows and spreads quickly, making it difficult to treat. Most patients with this diagnosis are not given much hope, but Hanchette’s i...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...
  • When Sheldon Querido, a retired manufacturer’s representative, was diagnosed with bladder cancer, his doctor told him that he’d need to have his bladder removed – and that he’d have to wear an external urine-collection bag for the rest of his life. “My first response was ‘I donR...
  • To stop smoking, two approaches might be better than one. A new study has found that using the medication varenicline, or Chantix – along with nicotine patches – was more effective than the medicine alone in helping people quit. The study, conducted by Stellanbosch University in Cape Town, South Africa, and pub...
  • John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission. His parents Bill and Gina, along with John and his younger brother Steve, r...
  • News about the risks or benefits of widespread cancer screening seem to arrive daily – 3D mammography for breast cancer, CT scans for lung cancer, PSA tests for prostate cancer and now pelvic exams for some women’s cancers. Missing in the headlines is a reflection of how cancer detection is evolving. Today’s ca...
  • Adults with sickle cell disease soon may have a new treatment option: bone marrow transplants. Children with sickle cell disease have been treated successfully with transplantation of bone marrow, more officially known as hematopoietic stem cells, from other people. But the procedure has been less successful in...